This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Di Costanzo F, Ravasio R, Sobrero A, Bertetto O, Vinante O, Luppi G, Labianca R, Amadori D, Barone C, Merlano MC, Longo F, Mansueto G, Antonuzzo L, Gasperoni S.Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer: economic evaluation in an Italian NHS setting. Clinical Drug Investigation 28: 645-655, No. 10, 2008
Rights and permissions
About this article
Cite this article
Capecitabine dominant in Dukes' C colon cancer. Pharmacoecon. Outcomes News 563, 5 (2008). https://doi.org/10.2165/00151234-200805630-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805630-00010